Nitrogen dioxide exposure attenuates cigarette smoke-induced cytokine production in mice. 2008

Corry-Anke Brandsma, and Machteld N Hylkema, and Marjan A Luinge, and Marie Geerlings, and Pieter A Klok, and Flemming R Cassee, and Wim Timens, and Dirkje S Postma, and Huib A M Kerstjens
Department of Pulmonary Diseases, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. c.a.brandsma@path.umcg.nl

Cigarette smoke is the most important cause for the development of chronic obstructive pulmonary disease (COPD). Since only a minority of smokers and some nonsmokers develop COPD, other factors must be involved as well. NO2 is an important air pollutant associated with respiratory symptoms in humans and emphysema development in animal models. We hypothesized that combined exposure to NO2 and cigarette smoke will enhance pulmonary inflammation and emphysema development. Mice were exposed to 20 ppm NO2 for 17 h/day, to 24 puffs of cigarette smoke 2 times per day, to their combination, or to control air for 5 days/wk during 4 wk. Following the last NO2 exposure and within 24 h after the last smoke exposure the mice were sacrificed. Lungs were removed and analyzed for several inflammatory parameters and emphysema. Cigarette smoke exposure increased eosinophil numbers and levels of tumor necrosis factor (TNF)-alpha, KC, monocyte chemoattractant protein (MCP)-1, and interleukin (IL)-6. NO2 exposure increased goblet cells, eosinophils, and the levels of IL-6, while it decreased the levels of IL-10. Four weeks of NO2, cigarette smoke, or their combination was not sufficient to induce significant emphysema, nor did it lead to increased numbers of lymphocytes, neutrophils, or macrophages in lung tissue. Instead, NO2 exposure attenuated the smoke-induced increases in levels of TNF-alpha, KC, and MCP-1. These dampening effects of NO2 may be due to modulating effects of NO2 on cytokine production by macrophages and epithelial cells, which have been reported earlier. The next step is to translate these findings of combined, controlled exposure in animals to the human situation.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D009585 Nitrogen Dioxide Nitrogen oxide (NO2). A highly poisonous gas. Exposure produces inflammation of lungs that may only cause slight pain or pass unnoticed, but resulting edema several days later may cause death. (From Merck, 11th ed) It is a major atmospheric pollutant that is able to absorb UV light that does not reach the earth's surface. Nitrogen Peroxide,Dioxide, Nitrogen,Peroxide, Nitrogen
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004336 Drug Antagonism Phenomena and pharmaceutics of compounds that inhibit the function of agonists (DRUG AGONISM) and inverse agonists (DRUG INVERSE AGONISM) for a specific receptor. On their own, antagonists produce no effect by themselves to a receptor, and are said to have neither intrinsic activity nor efficacy. Antagonism, Drug,Antagonisms, Drug,Drug Antagonisms
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004646 Emphysema A pathological accumulation of air in tissues or organs.
D004804 Eosinophils Granular leukocytes with a nucleus that usually has two lobes connected by a slender thread of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and stainable by eosin. Eosinophil

Related Publications

Corry-Anke Brandsma, and Machteld N Hylkema, and Marjan A Luinge, and Marie Geerlings, and Pieter A Klok, and Flemming R Cassee, and Wim Timens, and Dirkje S Postma, and Huib A M Kerstjens
February 2008, American journal of respiratory cell and molecular biology,
Corry-Anke Brandsma, and Machteld N Hylkema, and Marjan A Luinge, and Marie Geerlings, and Pieter A Klok, and Flemming R Cassee, and Wim Timens, and Dirkje S Postma, and Huib A M Kerstjens
April 2015, Inflammation,
Corry-Anke Brandsma, and Machteld N Hylkema, and Marjan A Luinge, and Marie Geerlings, and Pieter A Klok, and Flemming R Cassee, and Wim Timens, and Dirkje S Postma, and Huib A M Kerstjens
September 2019, Food research international (Ottawa, Ont.),
Corry-Anke Brandsma, and Machteld N Hylkema, and Marjan A Luinge, and Marie Geerlings, and Pieter A Klok, and Flemming R Cassee, and Wim Timens, and Dirkje S Postma, and Huib A M Kerstjens
April 2009, American journal of physiology. Lung cellular and molecular physiology,
Corry-Anke Brandsma, and Machteld N Hylkema, and Marjan A Luinge, and Marie Geerlings, and Pieter A Klok, and Flemming R Cassee, and Wim Timens, and Dirkje S Postma, and Huib A M Kerstjens
June 2016, The Journal of pharmacology and experimental therapeutics,
Corry-Anke Brandsma, and Machteld N Hylkema, and Marjan A Luinge, and Marie Geerlings, and Pieter A Klok, and Flemming R Cassee, and Wim Timens, and Dirkje S Postma, and Huib A M Kerstjens
February 2012, The European respiratory journal,
Corry-Anke Brandsma, and Machteld N Hylkema, and Marjan A Luinge, and Marie Geerlings, and Pieter A Klok, and Flemming R Cassee, and Wim Timens, and Dirkje S Postma, and Huib A M Kerstjens
August 2015, European journal of pharmacology,
Corry-Anke Brandsma, and Machteld N Hylkema, and Marjan A Luinge, and Marie Geerlings, and Pieter A Klok, and Flemming R Cassee, and Wim Timens, and Dirkje S Postma, and Huib A M Kerstjens
January 2015, International journal of clinical and experimental medicine,
Corry-Anke Brandsma, and Machteld N Hylkema, and Marjan A Luinge, and Marie Geerlings, and Pieter A Klok, and Flemming R Cassee, and Wim Timens, and Dirkje S Postma, and Huib A M Kerstjens
May 2012, International immunopharmacology,
Corry-Anke Brandsma, and Machteld N Hylkema, and Marjan A Luinge, and Marie Geerlings, and Pieter A Klok, and Flemming R Cassee, and Wim Timens, and Dirkje S Postma, and Huib A M Kerstjens
August 2019, Respiratory physiology & neurobiology,
Copied contents to your clipboard!